Engineered immune cells take on tough liver tumors
Disease control
Recruiting now
This study tests a new cell therapy for people with advanced liver cancer that has not responded to standard treatments. The therapy uses the patient's own immune cells, which are modified in the lab to better recognize and attack cancer cells. The goal is to see if this approach…
Phase: PHASE1, PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated May 01, 2026 16:00 UTC